Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000912057-97-010572
Filing Date
1997-03-28
Accepted
1997-03-28 00:00:00
Documents
5
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 10-K405 10-K405 246424
2 COMPUTATION OF PRO FORMA NET LOSS PER SHARE EX-11.1 4593
3 CONSENT OF PRICE WATERHOUSE EX-23.1 443
4 POWER OF ATTORNEY EX-24.1 162
5 FINANCIAL DATA SCHEDULE EX-27 2264
  Complete submission text file 0000912057-97-010572.txt   255796
Mailing Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Filer) CIK: 0001022622 (see all company filings)

EIN.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-21589 | Film No.: 97566258
SIC: 2834 Pharmaceutical Preparations